BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » viacord » Page 2

Why I Respectfully Disagree with Other Market Intelligence Reports about Cord Blood Banking

January 7, 2016 By Cade Hildreth (CEO) Leave a Comment

Cord Blood Industry Growth Rates

Recently, I’ve seen posts on LinkedIn and the web for a cord blood market report titled “Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 – 2020.”

I rarely reflect on products by other companies, but this report is disturbing in that it is painfully inaccurate.

As global business expert Joe Polish likes to say, “The most expensive information is bad information,” and this is a case of that situation.

In the Executive Summary, a highlight of the main findings for this report, Allied Market Research states that the “Cord blood market is expected to grow at 33.5% CAGR from 2012-2020.”
[Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: china cord blood corporation, cord blood, Cord Blood Registry, hematopoietic stem cells, market research, market size, viacord

3 Eerie Similarities between the Acquisition of Cord Blood Registry® (CBR) and ViaCord

July 9, 2015 By Cade Hildreth (CEO) Leave a Comment

CBR® ACQUIRED BY AMAG PHARMA FOR SAME MULTIPLE ON REVENUE AS PERKINELMER PAID FOR VIACORD

Cord Blood Registry® (CBR) recently made headlines by announcing that it had entered into a definitive agreement to be acquired by AMAG Pharmaceuticals for $700M. While the announcement was new, there were aspects of the deal that seemed eerily familiar.
[Read more…]

Filed Under: Cord Blood, HSCs Tagged With: AMAG Pharmaceuticals, cord blood, Cord Blood Registry, PerkinElmer, viacord

3 Eerie Similarities between the Acquisition of Cord Blood Registry® and ViaCord  

July 9, 2015 By Cade Hildreth (CEO) Leave a Comment

CBR® ACQUIRED BY AMAG PHARMA FOR SAME MULTIPLE ON REVENUE AS PERKINELMER PAID FOR VIACORD

Cord Blood Registry® recently made headlines by announcing that it had entered into a definitive agreement to be acquired by AMAG Pharmaceuticals. While the announcement was new, there were aspects of the deal that seemed eerily familiar.

CBR® Acquired by AMAG Pharma for Same Multiple on Revenue as PerkinElmer Paid for ViaCord

In particular, three aspects were strangely reminiscent of the deal in which PerkinElmer acquired the cord blood bank ViaCord in 2007.
[Read more…]

Filed Under: Cord Blood Tagged With: AMAG Pharmaceuticals, cord blood, cord blood banks, Cord Blood Registry, PerkinElmer, viacord

  • « Previous Page
  • 1
  • 2

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.